← Dashboard
Sep 07, 2026 07:17 PM ET
Signal
FDA/Bio
Roche Holding (SWX:ROP) Received FDA Clearance For An Alzheimer’s Blood Test
FDA clearance for Alzheimer’s blood test is a major regulatory catalyst for Roche.
What changed
Why it matters
FDA clearance for Alzheimer’s blood test is a major regulatory catalyst for Roche.
Sources
eodhd
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →
PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →
UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →